Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Telran distribution clearance

24 Oct 2011 07:00

RNS Number : 6646Q
Toumaz Limited
24 October 2011
 



24 October 2011

 

Toumaz Limited

 

Telran chip cleared for US and European distribution

 

Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in low cost, ultra-low power wireless communications technology, announces that its Telran TZ1053TDK, Toumaz's flagship low voltage and low power communications microchip, has passed the FCC regulatory requirements of three international standards for radios. The FCC (Federal Communications Commission) is the regulatory authority for radio and telecommunications equipment in the USA.

 

This means that Toumaz will be able to deliver Telran to customers in the key US markets and in Europe through the CE approval.

 

The TZ1053TDK TELRAN uses Toumaz's AMxTM state-of-the-art ultra-low energy technology to deliver significantly longer life from single cell 1V battery-based systems for customers developing ultra-low energy applications.

 

Target applications include the development of two-way communication remote controls for consumer electronic devices, wireless sensor networks for environment monitoring and room temperature control, remote controls toys and games and smart metering.

 

The testing was carried out by an independent certified body, TUV Sud, and covers specified RF, safety, EMC and ESD measurements as defined in each standard.

 

Professor Chris Toumazou Toumaz CEO commented:

 

"This is an important development milestone for us. We are now able to provide both our US and European customers, in the rapidly growing home consumer wireless markets, with one of the most effective low power, short range communications chips."

 

Enquiries:

 

Toumaz Limited 

020 7355 0036

Chris Toumazou, Chief Executive Officer

 

Patrick Stephansen, Chief Financial Officer

 

 

 

FinnCap

020 7600 1658

Charles Cunningham (Corporate Finance)

 

Brian Patient (Corporate Broking)

 

 

 

College Hill

020 7457 2020

Adrian Duffield/Rozi Morris

 

 

About Toumaz (www.toumazltd.com)

 

Toumaz is pioneering low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.

 

Targeting the healthcare market, Toumaz's ultra-low power sensor platform, Sensium™, is a leader in real-time wireless monitoring of the body's vital signs. Sensium™ has the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible personalised healthcare.

 

Toumaz also uses its expertise to design devices for wireless connectivity and internet-connected consumer products. Toumaz currently supplies multimedia/FM/DAB chips and complete modules to leaders in the digital radio market, such as PURE.

 

Toumaz is an AIM listed company (AIM: TMZ) with development centres in Oxford, UK and Taipei City, Taiwan.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKEFASPFFFF
Date   Source Headline
18th Sep 20157:00 amRNSBlock Listing Interim Review
19th Aug 20157:00 amRNSTotal Voting Rights
3rd Aug 20157:00 amRNSHalf year trading update
13th Jul 20157:00 amRNSSt James's University Hospital trial
10th Jun 20157:00 amRNSCo-development agreement with Google
3rd Jun 201511:16 amRNSBoard change
29th May 20158:00 amRNSTotal Voting Rights
28th May 201510:20 amRNSResult of AGM
28th May 20157:00 amRNSTrading update
30th Apr 20158:00 amRNSTotal Voting Rights
21st Apr 20157:01 amRNSQueen Elizabeth Hospital trials SensiumVitals
21st Apr 20157:00 amRNSFull year results
1st Apr 201510:00 amRNSNotice of Results
19th Mar 20158:00 amRNSBlocklisting Interim Review
3rd Mar 20157:00 amRNSNorth American Healthcare distribution
29th Jan 20157:00 amRNSTrading update
28th Jan 20158:00 amRNSToumaz Employee Long Term Incentive Plan
28th Nov 20148:00 amRNSTotal Voting Rights
25th Sep 20147:00 amRNSHalf Yearly Report
5th Sep 20147:00 amRNSFrontier Silicon launches new digital radio module
4th Sep 20142:00 pmRNSFrontier Silicon supply agreement with Philips
27th Aug 201410:00 amRNSNotice of Results
19th Aug 20148:00 amRNSIssue of Equity
1st Aug 20147:00 amRNSTrading update
31st Jul 20148:00 amRNSTotal Voting Rights
29th Jul 20147:00 amRNSSensium awarded Technology Strategy Board funding
30th Jun 20147:00 amRNSSouth African distribution for SensiumVitals
26th Jun 20148:00 amRNSEmployee Long Term Incentive Plan
23rd May 20144:34 pmRNSResult of AGM
23rd May 20147:00 amRNSTrading Update
20th May 20147:00 amRNSFrontier Silicon gains Digital Tick Mark approval
8th May 20147:00 amRNSMiddle East distribution for SensiumVitals®
28th Apr 201410:00 amRNSIssue of Equity
14th Apr 20147:00 amRNSNew radio chip and module preview
31st Mar 20147:00 amRNSFull year results
26th Mar 20147:00 amRNSSensiumVitals® expands distribution network
24th Mar 20147:00 amRNSPioneer selects Frontier Silicon's technology
7th Mar 20142:42 pmRNSNotice of Results
31st Jan 201410:00 amRNSTotal Voting Rights
17th Jan 20147:00 amRNSYear-end trading update
16th Dec 20137:00 amRNSFrontier Silicon extends Imagination partnership
25th Nov 201310:47 amRNSResult of EGM
25th Nov 20137:00 amRNSVenice module wins industry excellence award
13th Nov 20137:00 amRNSPatrick Hannon elected President of WorldDMB
7th Nov 20137:00 amRNSPlacing
15th Oct 20137:00 amRNSSensiumVitals: CE marking & UK hospital pilot
15th Oct 20137:00 amRNSDistribution agreement: first commercial US orders
23rd Sep 20137:00 amRNSHalf Year Results
9th Sep 20137:00 amRNSSpotify Connect Agreement
5th Sep 201311:20 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.